Cargando…

Association for Human Pharmacology in the Pharmaceutical Industry conference 2022: impending change, innovations and future challenges

The Association for Human Pharmacology in the Pharmaceutical Industry’s annual meeting focused on current and impending challenges facing the United Kingdom’s (UK) pharmaceutical industry and how these opportunities can inspire innovation and best practice. The UK pharmaceutical landscape is still e...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mundy, Charles, Bush, James, Cheriyan, Joseph, Lorch, Ulrike, Stringer, Steffan, Taubel, Jörg, Wydenbach, Kirsty, Hardman, Timothy C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10651721/ https://www.ncbi.nlm.nih.gov/pubmed/38026971 http://dx.doi.org/10.3389/fphar.2023.1219591

Ejemplares similares

The Association for Human Pharmacology in the Pharmaceutical Industry London Meeting October 2019: Impending Change, Innovation, and Future Challenges
por: Khan, Shahzadgai, et al.
Publicado: (2020)

The Association for Human Pharmacology in the Pharmaceutical Industry London Meeting 2018: Brexit and Other Challenges in Early Phase Drug Development
por: Reijntjes, Susan, et al.
Publicado: (2018)

The Power of Phase I Studies to Detect Clinical Relevant QTc Prolongation: A Resampling Simulation Study
por: Ferber, Georg, et al.
Publicado: (2015)

Three steps to writing adaptive study protocols in the early phase clinical development of new medicines
por: Lorch, Ulrike, et al.
Publicado: (2014)

Blinding Is Seeing: A Single-Centre Study Into the Viability of Auto-Injectors for Blinded-Drug Administration in Randomised Controlled Trials
por: Aggarwal, Vishal, et al.
Publicado: (2023)

Five trends of China's pharmaceutical industry in 2022
por: Chen, Yue, et al.
Publicado: (2023)

Safety, Tolerability, and Dose Proportionality of a Novel Transdermal Fentanyl Matrix Patch and Bioequivalence With a Matrix Fentanyl Patch: Two Phase 1 Single‐Center Open‐Label, Randomized Crossover Studies in Healthy Japanese Volunteers
por: Lorch, Ulrike, et al.
Publicado: (2020)

The Reliability of Auto-Injectors in Clinical Use: A Systematic Review
por: Dostal, Petr, et al.
Publicado: (2023)

Pharmacokinetics, Safety and Cognitive Function Profile of Rupatadine 10, 20 and 40 mg in Healthy Japanese Subjects: A Randomised Placebo-Controlled Trial
por: Täubel, Jörg, et al.
Publicado: (2016)

EUFEMED London Conference 2017: Exploratory Medicines Development: Innovation and Risk Management
por: Van Bortel, Luc, et al.
Publicado: (2018)

Measure on innovation efficiency of China's pharmaceutical manufacturing industry
por: Zhong, Shen, et al.
Publicado: (2022)

Single Doses up to 800 mg of E-52862 Do Not Prolong the QTc Interval – A Retrospective Validation by Pharmacokinetic-Pharmacodynamic Modelling of Electrocardiography Data Utilising the Effects of a Meal on QTc to Demonstrate ECG Assay Sensitivity
por: Täubel, Jörg, et al.
Publicado: (2015)

Thorough QT study of the effect of intravenous amisulpride on QTc interval in Caucasian and Japanese healthy subjects
por: Täubel, Jörg, et al.
Publicado: (2016)

Time- and Race-Specific Haematological Reference Intervals for Healthy Volunteer Trials: A Retrospective Analysis of Pooled Data From Multiple Phase I Trials
por: Coates, Simon, et al.
Publicado: (2020)

The Pharmaceutical Industry in 2022: An Analysis of FDA Drug Approvals from the Perspective of Molecules
por: de la Torre, Beatriz G., et al.
Publicado: (2023)

Kinetics of anti-SARS-CoV-2 IgG antibody levels and potential influential factors in subjects with COVID-19: A 11-month follow-up study
por: Luo, Huanyuan, et al.
Publicado: (2021)

European Federation for Exploratory Medicines Development Lyon Conference 2019: The Changing Landscape of Early Medicines Development—Be Prepared
por: Hardman, Tim, et al.
Publicado: (2019)

Identifying critical drivers of innovation in pharmaceutical industry using TOPSIS method
por: Damle, Madhavi, et al.
Publicado: (2022)

Confirmation of the Cardiac Safety of PGF(2α) Receptor Antagonist OBE022 in a First‐in‐Human Study in Healthy Subjects, Using Intensive ECG Assessments
por: Täubel, Jörg, et al.
Publicado: (2018)

The Treatment of an Impending Calamity
Publicado: (1908)

The Impending Medical Revolution
por: Marinker, Marshall
Publicado: (1968)

Major Pharmaceutical Conferences and Courses: June to July 2022
Publicado: (2022)

Regional technology gap and innovation efficiency trap in Chinese pharmaceutical manufacturing industry
por: Lai, Hongbo, et al.
Publicado: (2020)

The Impact of Compensation Gap on Corporate Innovation: Evidence from China’s Pharmaceutical Industry
por: Fu, Liping, et al.
Publicado: (2022)

How Technological Innovation Affect China's Pharmaceutical Smart Manufacturing Industrial Upgrading
por: Wang, Su, et al.
Publicado: (2021)

Present Systems and the Impending Education
por: Thompson, A. H.
Publicado: (1883)

Case of Impending Diabetic Coma
por: McHatton, H.
Publicado: (1893)

Acknowledgment to the Reviewers of Pharmaceuticals in 2022
Publicado: (2023)

Acknowledgment to the Reviewers of Pharmaceutics in 2022
Publicado: (2023)

Health assessment of innovative ecological rainforest in pharmaceutical industry: Case study of Zhejiang, China
por: Dong, Ying, et al.
Publicado: (2023)

HPLC in the pharmaceutical industry /
Publicado: (1991)

Immunotoxicology in the pharmaceutical industry.
por: Norbury, K C
Publicado: (1982)

Interacting with the Pharmaceutical Industry
por: Hayden, Stephen R.
Publicado: (2003)

Pharmaceutical Industry in Syria
por: Kutaini, D
Publicado: (2010)

Confirmation of the cardiac safety of nolasiban in a randomised cohort of healthy female volunteers
por: Täubel, Jörg, et al.
Publicado: (2021)

Evolutionary Path and Innovative Development of Pharmaceutical Industrial Cluster—A Case Study of Shijiazhuang, China
por: Fu, Liping, et al.
Publicado: (2022)

The Role of Desorptive Capacity in the Relationship of Entrepreneurial Orientation - Open Innovation Performance: The Case of the Pharmaceutical Industry
por: Yektadoost, Alireza, et al.
Publicado: (2021)

Anthocyanins: Metabolic Digestion, Bioavailability, Therapeutic Effects, Current Pharmaceutical/Industrial Use, and Innovation Potential
por: Ayvaz, Huseyin, et al.
Publicado: (2022)

E-waste hazard: The impending challenge
por: Pinto, Violet N.
Publicado: (2008)

Position in Impending Death from Chloroform
Publicado: (1869)

Cannot write session to /tmp/vufind_sessions/sess_oifuk5rsr8q27gng9mavvhs5o0